The Relationship between Cocaine Use and Human Papillomavirus Infections in HIV-Seropositive and HIV-Seronegative Women
Table 1
Selected
baseline characteristics of cocaine users and noncocaine users in last 6 months at baseline in the Women’s Interagency HIV Study*.
Characteristic
N (%)
-value
Used crack/cocaine1 in last 6 months
Yes
No
Total
726 (%)
2761 (%)
—
Age (yr)
<.0001**
<30
116 (16)
914 (33)
—
30–34
160 (22)
680 (25)
—
35–39
207 (29)
607 (22)
—
40–44
171 (24)
339 (12)
—
>=45
72 (10)
221 (8)
—
Race
<.0001
White
95 (13)
433 (16)
—
Hispanic
121 (17)
829 (30)
—
African American
494 (68)
1397 (51)
—
Others
16 (2)
102 (4)
—
HIV
status and CD4 T-cell count
0.0559**
HIV-negative
218 (31)
694 (26)
HIV-positive
CD4>500
150 (21)
664 (25)
—
200≤CD4≤500
212 (30)
859 (32)
—
CD4<200
121 (17)
490 (18)
—
Number of male sex partners in
past 6 months
<.0001**
0
155 (22)
772 (28)
—
1 (married)
80 (11)
506 (18)
—
1 (single)
223 (31)
1049 (38)
—
2
97 (14)
266 (10)
—
>2
160 (22)
159 (6)
—
Smoking
status
<.0001**
None
60 (8)
1106 (40)
—
Former smoker
37 (5)
483 (18)
—
Current smoker <10 pack-years
282 (39)
706 (26)
—
Current smoker >=10 pack-years
344 (48)
456 (17)
—
Frequency
of crack/cocaine use
Less than once per month
131 (18)
NA
—
Once per month—once per week
224 (31)
NA
—
2–6 times per week
185 (25)
NA
—
Once per day or more
180 (25)
NA
—
*Limited
to those contributing data to the present analysis. Some data were missing at
baseline for selected patients. Percentages do not always add up to 100% due to
rounding.**Two-sided Cochran-Mantel-Haenszel test. All other P values were determined with the two-sided Pearson’s chi-square test.
